Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
Effectiveness of a Multilevel Integrated Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
2 other identifiers
interventional
250
1 country
2
Brief Summary
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 17, 2025
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
May 8, 2026
April 1, 2026
4.1 years
April 24, 2026
April 30, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Stage of Change for Smoking Cessation
Stage of change in smoking cessation behavior
Baseline, immediately post-intervention, and 6-month follow-up
7-Day Point Prevalence Abstinence Rate
Proportion of participants reporting no smoking in the past 7 days
Baseline, immediately post-intervention, and 6-month follow-up
24-Hour Point Prevalence Abstinence Rate
Proportion of participants reporting no smoking in the past 24 hours
Baseline, immediately post-intervention, and 6-month follow-up
Daily Cigarette Consumption
Number of cigarettes smoked per day
Baseline, immediately post-intervention, and 6-month follow-up
Nicotine Dependence (Fagerström Test for Nicotine Dependence)
Nicotine dependence measured using the Fagerström Test for Nicotine Dependence (FTND), range 0-10, higher scores indicate greater dependence
Baseline, immediately post-intervention, and 6-month follow-up
Secondary Outcomes (2)
Lung Cancer Screening (LDCT) Uptake
Baseline, immediately post-intervention, 6 months
Intent to Undergo Lung Cancer Screening
Baseline, immediately post-intervention, 6 months
Study Arms (2)
Control
NO INTERVENTIONNo intervention
Screening
EXPERIMENTALLDCT lung cancer screening
Interventions
The intervention will utilize a multilevel intervention based on the Social Ecological Model's individual, institutional, and community levels.
Eligibility Criteria
You may qualify if:
- African American
- + pack years of smoking
- eligible for or received LDCT screening
- current smoker
- English speaking
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
LSUHSC School of Public Health
New Orleans, Louisiana, 70112, United States
University Medical Center
New Orleans, Louisiana, 70112, United States
Related Publications (1)
Ahmad, A., & Singh, J. (2022). Influence of Processes of Change on Stages of Change for Smoking Cessation. Journal of Applied Social Science, 16(1), 209-222. https://doi.org/10.1177/19367244211036994 Andritsou, M., Schoretsaniti, S., Litsiou, E., Saltagianni, V., Konstadara, K., Spiliotopoulou, A., Zakynthinos, S., & Katsaounou, P. (2016). Success rates are correlated mainly to completion of a smoking cessation program. European Respiratory Journal, 48. https://doi.org/10.1183/13993003.congress-2016.PA4599 Baker, T. B., Burris, J. L., & Fiore, M. C. (2022). Helping African American individuals quit smoking: Finally, some progress. JAMA, 327(22), 2192-2194. Baker, T. B., Mermelstein, R., Collins, L. M., Piper, M. E., Jorenby, D. E., Smith, S. S., Christiansen, B. A., Schlam, T. R., Cook, J. W., & Fiore, M. C. (2011). New methods for tobacco dependence treatment research. Annals of Behavioral Medicine, 41(2), pp.192-207. https://doi.org/10.1007/s12160-010-9252-y Collins, L. M., Baker, T. B., Mermelstein, R. J., Piper, M. E., Jorenby, D. E., Smith, S. S., ... & Fiore, M. C. (2011). The multiphase optimization strategy for engineering effective tobacco use interventions. Annals of Behavioral Medicine, 41(2), pp.208-226. Cornelius, M. E., Loretan, C. G., Jamal, A., Lynn, B. C. D., Mayer, M., Alcantara, I. C., & Neff, L. (2023). Tobacco Product Use Among Adults-United States, 2021. Morbidity and Mortality Weekly Report, 72(18), pg.475. Etter, J. F., Vu Duc, T., & Perneger, T. V. (1999). Validity of the Fagerström test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction (Abingdon, England), 94(2), 269-281. https://doi.org/10.1046/J.1360-0443.1999.94226910.X Fedewa, S. A., Kazerooni, E. A., Studts, J. L., Smith, R. A., Bandi, P., Sauer, A. G., ... & Silvestri, G. A. (2021). State variation in low-dose computed tomography scanning for lung cancer screening in the United States. Journal of the National Cancer Institute, 113(
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tung Sung Tseng, DrPH, MS
LSUHSC New Orleans
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 8, 2026
Study Start
April 17, 2025
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 1, 2030
Last Updated
May 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share